Background & Aims Despite rescue therapy, more than 30% of patients with acute severe
ulcerative colitis (ASUC) require colectomy. Tofacitinib is a rapidly acting Janus kinase …

Background Dual targeted therapy (DTT) has emerged as an attractive therapeutic option
for select patients with active inflammatory bowel disease (IBD) who are unable to achieve …

Basic science advances in cancer immunotherapy have resulted in various treatments that
have recently shown success in the clinic. Many of these therapies require the insertion of …

Objectives The objectives of the study were to compile and summarize the data from all of
the clinical trials designed to examine the association between haptoglobin (Hp) genotype …

Purpose of Review Despite compelling evidence regarding the importance of oxidant stress
in the development of vascular complications and observational studies suggesting that …

Background Pain is commonly experienced by patients with inflammatory bowel disease (IBD).
Unfortunately, pain management is a challenge in IBD care, as currently available …

BACKGROUND & AIMS Acute severe ulcerative colitis (ASUC) is a life-threatening
presentation of ulcerative colitis requiring prompt treatment. Infliximab (IFX) rescue therapy can …

This book contains information from reputable sources and although reasonable efforts
have been made to publish accurate information, the publisher makes no warranties (either …

BACKGROUND: A significant proportion of patients with acute severe ulcerative colitis (ASUC)
require colectomy. METHODS: ASUC patients treated with upadacitinib and IV …

Prostate Cancer (PCa) is the third most common cancer type in the United States, with over
200,000 new cases projected to be diagnosed this year. In approximately 80% of PCa …